This inventor holds 16 USPTO granted patents and 11 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignees: Kashiv Biosciences, LLC, Kashiv Specialty Pharmaceuticals, LLC, Amneal Complex Products Research LLC. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 22 
4 out of 10 
3 out of 13 Years Active: 2011-2026
Title: Innovator Kanji Meghpara: Advancements in Gastroretentive Drug Delivery
Introduction
Kanji Meghpara is a prominent inventor based in Morris Plains, NJ, known for his significant contributions to the field of pharmaceutical formulations. With a remarkable portfolio of 15 patents, Meghpara has focused his innovations on creating advanced drug delivery systems that cater to critical therapeutic needs.
Latest Patents
Among Meghpara's latest patents are innovative gastroretentive dosage forms designed for sustained drug delivery. This technology features floating gastroretentive formulations that extend the residence time in the stomach, allowing for targeted release in the proximal gastrointestinal tract. Notable examples include:
1. **Gastroretentive dosage forms for sustained drug delivery**: This patent outlines floating dosage forms with a permeable elastic membrane, ensuring optimal drug release characteristics and mechanical strength to maintain tablet integrity.
2. **Sustained release compositions comprising liothyronine**: This patent introduces a multilayer core composed of a pull layer containing liothyronine and a push layer, both made from swellable, water-soluble hydrophilic polymers. The design incorporates a permeable elastic membrane with orifices for controlled release.
Career Highlights
Kanji Meghpara has made a significant impact in the pharmaceutical industry through his work with reputable companies, including Kashiv Biosciences, LLC and Kashiv Specialty Pharmaceuticals, LLC. His expertise in pharmaceutical chemistry and innovative drug delivery systems has been instrumental in advancing therapeutic treatments.
Collaborations
Throughout his career, Meghpara has collaborated with talented professionals such as Navnit Hargovindas Shah and Dipen Desai. These partnerships have fostered a dynamic environment for innovation, enabling the development of cutting-edge solutions in drug delivery.
Conclusion
Kanji Meghpara stands out as a visionary inventor whose contributions in the realm of gastroretentive drug delivery system have significantly enhanced pharmaceutical practices. With a growing portfolio of patents and continuous collaboration with industry experts, he is poised to drive further advancements in the healthcare field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile